Literature DB >> 16088299

Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?

Nitin Khosla1, Dave Y Chua, William J Elliott, George L Bakris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088299     DOI: 10.1111/j.1524-6175.2005.04451.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  18 in total

Review 1.  Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

Authors:  Sirirat Reungjui; Thongchai Pratipanawatr; Richard J Johnson; Takahiko Nakagawa
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

Review 2.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

3.  Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.

Authors:  Mohammed Siddiqui; Tanja Dudenbostel; David A Calhoun
Journal:  Can J Cardiol       Date:  2015-07-08       Impact factor: 5.223

Review 4.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

5.  Prevalence of Apparent Treatment-Resistant Hypertension in the United States.

Authors:  Robert M Carey; Swati Sakhuja; David A Calhoun; Paul K Whelton; Paul Muntner
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

6.  [Therapy-resistant and therapy-refractory arterial hypertension].

Authors:  M Wallbach; M J Koziolek
Journal:  Internist (Berl)       Date:  2018-06       Impact factor: 0.743

Review 7.  Resistant hypertension: concepts and approach to management.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

8.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 9.  Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

Review 10.  Treatment of Resistant and Refractory Hypertension.

Authors:  Maria Czarina Acelajado; Zachary H Hughes; Suzanne Oparil; David A Calhoun
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.